Press Releases

Recro Expands Capabilities for Growing Clinical Trial Services (CTS) Offerings

Jun 02, 2021 7:00am EDT

Recro Enters Development Agreement With Astex Pharmaceuticals

May 18, 2021 7:00am EDT

Recro Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

May 14, 2021 9:15am EDT

Recro Announces Pricing of $30.0 Million Public Offering of Common Stock

May 12, 2021 8:30am EDT

Recro Announces Proposed Public Offering of Common Stock

May 11, 2021 4:30pm EDT

Recro Reports First Quarter 2021 Financial Results

May 06, 2021 4:05pm EDT

Recro to Report Financial Results for First Quarter 2021 on May 6

Apr 29, 2021 4:05pm EDT

Recro Expands Development and Manufacturing Relationship With Ensysce Biosciences

Apr 15, 2021 7:00am EDT

Recro Reports Inducement Grants for New Staff

Apr 06, 2021 7:00am EDT

Recro Strengthens Business Development Team to Drive Customer Growth and Diversification

Apr 05, 2021 7:00am EDT

1
2
3
4
5
6
7
8
9
10
...20